Vaccination of transgenic HLA-A2/HER2 mice with a single dose of SEVs from DCs transfected with an adenoviral vector led to activating CD8+ T cell cytolytic functions against BC cells in vitro and reduced tumor growth in vivo [582]. This evidence concerns the gene ERBB2 and breast cancer.